PYXS Pyxis Oncology, Inc. Net earnings per share growth this year

PYXS (pyxisoncology.com) - company brandmark

Pyxis Oncology, Inc. (PYXS) develops ADC drugs to combat tumors, anticipating clinical breakthroughs and partnerships with industry behemoths. The EPS trajectory compared to last year confirms these expectations, with the current level sitting around 13.50. Future revenue is based on the commercialization of targeted therapy, while confidence in growth is bolstered by a strong cash position and the leadership experience of Lara Sullivan.

Pyxis Oncology (PYXS): Net earnings per share growth this year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company pyxisoncology.com (PYXS)

- current quotes and average value forecast:
Summary company analysis:PYXS (Pyxis Oncology)
Brand item of Pyxis Oncology, Inc.

This indicator measures the year-over-year dynamics of net earnings per share, identifying the real efficiency of value generation regardless of market volatility. For Pyxis Oncology, Inc. (PYXS), which develops R&D through patent licensing and alliances, this metric reflects the impact of operating expenses on capital, allowing for an assessment of the business's fundamental stability via the annual EPS growth chart level.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year CGEN (Compugen Ltd.)|Net earnings per one share growth for the current year IOBT|Earnings growth in current year STRO (Sutro Biopharma)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma|ALX Oncology (ALXO) - Earnings per share growth in current year|cuebiopharma.com (CUE) - Earnings growth in current year|PDSB (PDS Biotechnology Corp) - Earnings growth in current year|Earnings growth in current year sonnetbio.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year